Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674644 | SCV000800017 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger) | 2018-05-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003758907 | SCV004548028 | pathogenic | Zellweger spectrum disorders | 2023-08-11 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 558383). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. This variant is present in population databases (rs767877383, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.His951Glnfs*2) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). |
Fulgent Genetics, |
RCV005034279 | SCV005669704 | likely pathogenic | Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B | 2024-05-01 | criteria provided, single submitter | clinical testing |